Structure

InChI Key IECPWNUMDGFDKC-MZJAQBGESA-N
Smile CC(=O)O[C@H]1C[C@@]2(C)[C@@H](C[C@@H](O)[C@H]3[C@@]4(C)CC[C@@H](O)[C@@H](C)[C@@H]4CC[C@@]32C)/C1=C(\CCC=C(C)C)C(=O)O
InChI
InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C31H48O6
Molecular Weight 516.72
AlogP 5.67
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 5.0
Polar Surface Area 104.06
Molecular species ACID
Aromatic Rings 0.0
Heavy Atoms 37.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Elongation factor G inhibitor PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Keloid 3 D007627 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Infections 2 D007239 ClinicalTrials
Skin Diseases 2 D012871 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
CAS NUMBER 6990-06-3
ChEBI 29013
ChEMBL CHEMBL374975
DrugBank DB02703
DrugCentral 1261
EPA CompTox DTXSID0023086
FDA SRS 59XE10C19C
Human Metabolome Database HMDB0015570
Guide to Pharmacology 10815
PDB FUA
PharmGKB PA164749648
PubChem 3000226
SureChEMBL SCHEMBL25646
ZINC ZINC000008143796